Prioritizing Genetic Contributors to Cortical Alterations in 22q11.2 Deletion Syndrome Using Imaging Transcriptomics
- PMID: 33638978
- PMCID: PMC8196250
- DOI: 10.1093/cercor/bhab008
Prioritizing Genetic Contributors to Cortical Alterations in 22q11.2 Deletion Syndrome Using Imaging Transcriptomics
Abstract
22q11.2 deletion syndrome (22q11DS) results from a hemizygous deletion that typically spans 46 protein-coding genes and is associated with widespread alterations in brain morphology. The specific genetic mechanisms underlying these alterations remain unclear. In the 22q11.2 ENIGMA Working Group, we characterized cortical alterations in individuals with 22q11DS (n = 232) versus healthy individuals (n = 290) and conducted spatial convergence analyses using gene expression data from the Allen Human Brain Atlas to prioritize individual genes that may contribute to altered surface area (SA) and cortical thickness (CT) in 22q11DS. Total SA was reduced in 22q11DS (Z-score deviance = -1.04), with prominent reductions in midline posterior and lateral association regions. Mean CT was thicker in 22q11DS (Z-score deviance = +0.64), with focal thinning in a subset of regions. Regional expression of DGCR8 was robustly associated with regional severity of SA deviance in 22q11DS; AIFM3 was also associated with SA deviance. Conversely, P2RX6 was associated with CT deviance. Exploratory analysis of gene targets of microRNAs previously identified as down-regulated due to DGCR8 deficiency suggested that DGCR8 haploinsufficiency may contribute to altered corticogenesis in 22q11DS by disrupting cell cycle modulation. These findings demonstrate the utility of combining neuroanatomic and transcriptomic datasets to derive molecular insights into complex, multigene copy number variants.
Keywords: DGCR8; copy number variant; cortical thickness; gene expression; surface area.
© The Author(s) 2021. Published by Oxford University Press.
Figures
References
-
- Blomgren K, Leist M, Groc L. 2007. Pathological apoptosis in the developing brain. Apoptosis. 12:993–1010. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P41 EB015922/EB/NIBIB NIH HHS/United States
- R01 MH100900/MH/NIMH NIH HHS/United States
- R56 AG058854/AG/NIA NIH HHS/United States
- U01 MH101719/MH/NIMH NIH HHS/United States
- R01 MH119185/MH/NIMH NIH HHS/United States
- U01 MH119738/MH/NIMH NIH HHS/United States
- U01 MH101724/MH/NIMH NIH HHS/United States
- R01 MH107108/MH/NIMH NIH HHS/United States
- U54 EB020403/EB/NIBIB NIH HHS/United States
- U01 MH087626/MH/NIMH NIH HHS/United States
- T32 AG058507/AG/NIA NIH HHS/United States
- 100202/Z/12/Z/WT_/Wellcome Trust/United Kingdom
- R01 GM125757/GM/NIGMS NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R01 HD027694/HD/NICHD NIH HHS/United States
- MR/L010305/1/MRC_/Medical Research Council/United Kingdom
- U01 MH101723/MH/NIMH NIH HHS/United States
- UL1 TR001881/TR/NCATS NIH HHS/United States
- R37 MH085953/MH/NIMH NIH HHS/United States
- K08 MH118577/MH/NIMH NIH HHS/United States
- R01 MH111671/MH/NIMH NIH HHS/United States
- P01 HD070454/HD/NICHD NIH HHS/United States
- R01 MH116147/MH/NIMH NIH HHS/United States
- R01 MH057636/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
